What is Beam Therapeutics's investment purchases?

Beam Therapeutics (BEAM) reported investment purchases of $153.79M in Q1 2026.

How has Beam Therapeutics's investment purchases changed year-over-year?

Beam Therapeutics's investment purchases decreased by 54.7% year-over-year, from $339.17M to $153.79M.

What is the long-term trend for Beam Therapeutics's investment purchases?

Over 4 years (2021 to 2025), Beam Therapeutics's investment purchases has grown at a 11.7% compound annual growth rate (CAGR), from $777.22M to $1.21B.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Beam Therapeutics BEAM Investment Purchases

Investment Purchases at other companies

Vertex PharmaceuticalsVRTX

$2.51B+52.2%

Arrowhead ResearchARWR

$924.64M+43.5%

PTC TherapeuticsPTCT

$454.67M+41.1%

BridgeBio PharmaBBIO

$52.67M—

Protagonist TherapeuticsPTGX

$68.97M-67.8%

BiogenBIIB

$748.8M—

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.42B+24.5%

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's investment purchases?: Beam Therapeutics (BEAM) reported investment purchases of $153.79M in Q1 2026.
How has Beam Therapeutics's investment purchases changed year-over-year?: Beam Therapeutics's investment purchases decreased by 54.7% year-over-year, from $339.17M to $153.79M.
What is the long-term trend for Beam Therapeutics's investment purchases?: Over 4 years (2021 to 2025), Beam Therapeutics's investment purchases has grown at a 11.7% compound annual growth rate (CAGR), from $777.22M to $1.21B.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.